Viewing StudyNCT06402123



Ignite Creation Date: 2024-05-11 @ 8:30 AM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06402123
Status: RECRUITING
Last Update Posted: 2024-06-26
First Post: 2024-05-02

Brief Title: A Phase 2b Study of Zagociguat in Patients with MELAS
Sponsor: Tisento Therapeutics
Organization: Tisento Therapeutics

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-07-15
Start Date Type: ESTIMATED
Primary Completion Date: 2025-09-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-09-01
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-02
First Submit QC Date: May 2 2024
Study First Post Date: 2024-05-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-17
Last Update Post Date: 2024-06-26
Last Update Post Date Type: ACTUAL